Genomic Health Announces Multiple Studies Highlighting Important Role Of Oncotype DX®
Genomic Health, Inc. (Nasdaq: GHDX) announced results from seven new studies focusing on its multigene Oncotype DX® breast cancer test, which has helped guide treatment decisions in more than 175,000 breast cancer patients worldwide...